Interferon gamma Antikörper
-
- Target Alle Interferon gamma (IFNG) Antikörper anzeigen
- Interferon gamma (IFNG)
-
Reaktivität
- Maus
-
Wirt
- Ratte
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser Interferon gamma Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Neutralization (Neut)
- Marke
- BD Pharmingen™
- Produktmerkmale
-
The R4-6A2 antibody reacts with mouse interferon-γ (IFN-γ). The immunogen used to generate the R4-6A2 hybridoma was partially-purified mouse IFN-γ protein. This is a neutralizing antibody. This antibody is routinely tested by ELISA Capture. Other applications were tested during antibody development only or reported in the literature.
BD Pharmingen™ Purified Rat Anti-Mouse IFN-γ - Purified - Clone R4-6A2 - Isotype Rat IgG1, κ - Reactivity Ms - 1 mg - Aufreinigung
- The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.
- Immunogen
- Partially-Purified Mouse IFN-gamma
- Klon
- R4
- Isotyp
- IgG1 kappa
- Top Product
- Discover our top product IFNG Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 1.0 mg/mL
- Buffer
- Aqueous buffered solution containing ≤0.09 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Informationen zur Lagerung
- Store undiluted at 4°C.
-
-
Induction of cytokines in mice with parainfluenza pneumonia." in: Journal of virology, Vol. 69, Issue 2, pp. 1288-91, (1995) (PubMed).
: "Administration of anti-IFN-gamma antibody to beta 2-microglobulin-deficient mice delays influenza virus clearance but does not switch the response to a T helper cell 2 phenotype." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 153, Issue 3, pp. 1246-53, (1994) (PubMed).
: "Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands." in: Journal of virology, Vol. 66, Issue 4, pp. 1977-84, (1992) (PubMed).
: "Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples." in: Immunological reviews, Vol. 127, Issue 9-10, pp. 5-24, (1992) (PubMed).
: "Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism." in: The Journal of experimental medicine, Vol. 171, Issue 1, pp. 115-27, (1990) (PubMed).
: "Role of endogenous gamma interferon in host response to infection with blood-stage Plasmodium chabaudi AS." in: Infection and immunity, Vol. 58, Issue 10, pp. 3225-32, (1990) (PubMed).
: "
-
Induction of cytokines in mice with parainfluenza pneumonia." in: Journal of virology, Vol. 69, Issue 2, pp. 1288-91, (1995) (PubMed).
-
- Target
- Interferon gamma (IFNG)
- Andere Bezeichnung
- IFN-gamma (IFNG Produkte)
- Synonyme
- IFG antikoerper, IFI antikoerper, IFN-g antikoerper, Ifg antikoerper, IFNG2 antikoerper, IFN-gamma antikoerper, IFN-G antikoerper, IFNG antikoerper, IFNgamma antikoerper, TCRalpha antikoerper, INF-G antikoerper, ifng antikoerper, interferon gamma antikoerper, interferon, gamma 1-2 antikoerper, IFNG antikoerper, Ifng antikoerper, ifng1-2 antikoerper
- Pathways
- Interferon-gamma Pathway, Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, ER-Nucleus Signaling, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus, Autophagie
-